Solrom 2025: Is QCL really on the way to becoming a commercial engine?
Solrom's laser revenue did jump to NIS 2.286 million in 2025, but QCL still does not look like a fully formed commercial engine. The large July 2025 framework remained conditional on customer approval, and the operational proof from January and March 2026 is still too small to settle the debate.
Why This Follow-Up Matters
The main article argued that Solrom's defense core had improved, but that QCL still had to prove it could move from a technology story to a commercial one. This follow-up isolates only that question. Not whether the technology exists, and not whether there is customer interest, but whether the evidence already points to a repeatable commercialization mechanism.
The short answer upfront: there is real progress here. In 2025 the activity generated its first meaningful revenue and positive gross profit, and in January and March 2026 it also produced orders for operational use. But on the evidence in hand, QCL still does not look like a fully built commercial engine. It looks like a line that has crossed the initial feasibility threshold, while still relying on two tracks that are not fully closed: a larger component track that remains conditional, and a finished-product track with operational proof but still small volumes.
What is working now? Laser-system revenue rose to NIS 2.286 million in 2025, from NIS 436 thousand in 2024. At the same time, the activity moved from a gross loss of NIS 189 thousand to a gross profit of NIS 947 thousand. This is no longer a purely accounting pilot. There is now paying demand and a product that has started to show up in the income statement in a way that looks commercial.
What is still missing? Scale and certainty. Even after the jump, laser systems were only about 2.3% of Solrom's consolidated revenue in 2025. On the certainty side, the largest agreement disclosed so far, about NIS 24 million over five years, was still subject to technical compliance and written customer approval. At the same time, the finished-product track did receive operational validation, but by mid March 2026 it still rested on only NIS 286 thousand of firm orders.
What Has Already Been Proven
QCL has moved beyond the accounting-pilot stage
The 2025 progress is not just narrative. It is already visible in the numbers. Laser-system revenue grew by more than 5 times, from NIS 436 thousand in 2024 to NIS 2.286 million in 2025. Direct cost rose to NIS 1.339 million, but the important change is that the activity turned gross-profit positive, with a gross margin of about 41.4%. In other words, the debate is no longer whether QCL can be sold at all. The real debate is whether it can be sold repeatedly and at much greater scale.
That matters because the market often confuses an interesting technology with a product that has entered the company's cash cycle. At Solrom, 2025 was the first year in which the laser line showed a revenue layer that looks like the start of a market. That is materially different from 2024, when the line was still tiny and gross-loss making.
The company has already chosen how it wants to commercialize the technology
After the successful October 2025 trial, Solrom did not stop at selling QCL components into customer systems. It explicitly said it intends to focus mainly on finished QCL-based products, while continuing to develop and sell QCL components for existing defense-customer systems. That is strategically important because a commercial engine in finished products can become larger and potentially more valuable than a component-only model.
But that shift also raises the execution bar. Once the company chooses the finished-product route, the discussion is no longer only about the laser itself. It becomes a question of field reliability, integration, delivery capability, production pace and customer support. That is the point where technology has to start looking like a business.
What Is Hard Evidence, And What Is Still Optional
The problem in reading the QCL story is that the most eye-catching numbers are also the least rigid ones. To decide whether this is becoming a commercial engine, it helps to separate what has already been recognized or firmly ordered from what still sits on forecasts, options or customer approval.
| Track | What has already happened | Monetary value | Certainty | What it proves | What is still missing |
|---|---|---|---|---|---|
| QCL components for a defense customer | An original order of about NIS 1.5 million from October 2024 and a follow-on order of about NIS 850 thousand from May 2025, both fully supplied during 2025 | About NIS 2.35 million combined | Hard | There is a paying customer for QCL components, and the line already produced recognized revenue | The next step is to show that this becomes repeat business rather than just a first and second transaction |
| July 2025 framework agreement | A non-exclusive framework with a new customer for QCL components | About NIS 24 million over 5 years | Conditional | There is a meaningful commercial ceiling on paper | The agreement was conditioned on supplying 2 units of each component type by the end of March 2026 and on customer approval within up to 3 months from receipt |
| Finished products for the security forces | A firm January 2026 order that was supplied immediately, followed by another firm March 2026 order drawn from a framework order | NIS 76 thousand plus NIS 210 thousand | Hard | QCL has already crossed from demonstration into operational use | The volumes are still small and need to become a repeat ordering pattern rather than a one-off proof point |
| January 2026 framework order | A framework order for first units of two QCL-based laser markers | About NIS 1.24 million | Optional | There is an initial operational need signal | By mid March 2026, only NIS 210 thousand from that framework had turned into a firm order |
This is the core of the story. On one hand, QCL can no longer be dismissed as promise only. On the other hand, the hard evidence in the filings is still relatively small. 2025 ended with NIS 2.286 million of recognized laser-system revenue, and after the balance-sheet date only NIS 286 thousand of firm orders had been added. The gap between what has already been proven and what the headlines suggest is still wide.
The July 2025 framework is the sharpest example. On one hand, it shows that a new customer is willing to discuss a multi-year framework. On the other hand, even the customer's indicative 2026 volume, about NIS 2.6 million, would by itself be larger than all of 2025 laser revenue. That is exactly why the agreement matters, and exactly why its conditional nature matters even more.
The Bottlenecks That Are Still Open
First, the product still has to clear the customer's threshold
Solrom itself frames the central risk in fairly direct terms: the products may fail to reach the technological threshold needed to justify their value in the market. This is not a side risk disclosure. It is the heart of the commercial debate. That is why the roughly 30% improvement in laser power, which the company disclosed in February 2025, matters. It signals that the company is still working to improve performance in order to broaden use cases and the customer base, not operating from a position where the product is already fully settled.
In that context, the July 2025 framework is not only an opportunity. It is also a test. It contains a clear customer requirement, supply of 2 units from each component type by the end of March 2026, followed by written customer approval. Put differently, the customer has already put a possible commercial path on the table, but has not removed the qualification step.
Commercialization also means operational muscle
The company explicitly says that critical success factors include skilled manpower and the ability to broaden operational and manufacturing disciplines. That sounds technical, but for QCL it is directly commercial. As long as the story is about selling a component, the execution burden is lighter. Once Solrom talks about two QCL-based laser markers for operational use, the debate shifts to whether it can supply a full product, repeat the delivery and scale the production base without damaging quality.
That is also the difference between the January and March orders. January proved that the product had crossed into operational use rather than staying at trial level. March starts to test whether the company can move from a small initial order toward a wider route with additional units. It is still far from a serial-production proof, but it is already an operational test, not just a technological one.
Revenue is already here, but investment is still running ahead of it
It is too early to call QCL a commercial engine when the economics of this phase still rest on heavy build-out spending. In 2025, R&D expense attributed to adapting the QCL technology to the defense market reached NIS 5.906 million, more than 2.5 times that year's laser revenue. In the fourth quarter, R&D expense fell because the company received approval for an Israel Innovation Authority grant of about NIS 2.5 million, of which about NIS 1.3 million had been received by the end of 2025.
The point is not that the activity is weak. The point is that it is still being built. As long as the revenue layer remains relatively small and the development layer remains heavy, the economic model is still one of capability build-out rather than commercial harvesting. A true commercial engine has to show that revenue starts to run after the investment, not only justify its existence.
What Needs To Happen Over The Next 2 To 4 Quarters
The next stage for QCL is already fairly clear. It does not need another general statement about potential. It needs a few very concrete checks.
Checkpoint one: customer approval for the July 2025 component route. Until that happens, the largest agreement remains mostly a framework with potential rather than a revenue base.
Checkpoint two: delivery and recognition of the March 2026 order during the second quarter of 2026. That is the nearest chance to see whether the operational route is actually starting to roll into the numbers.
Checkpoint three: conversion of the January 2026 framework order into more firm orders. On the evidence in hand, only NIS 210 thousand from the framework itself had turned firm, and total firm post-balance-sheet orders stood at NIS 286 thousand. To call this a commercial engine, both numbers need to start moving faster.
Checkpoint four: a visible change in the weight of QCL within 2026 results. If the laser line remains a low single-digit share of revenue even after another full year, it will be hard to call it an engine. If it starts to take a visible share and repeat orders, the debate changes materially.
Conclusion
This analysis does not leave much room for the middle ground. QCL is no longer just slideware. There is revenue, there is gross profit, there is a successful trial that turned into operational orders, and there is another customer willing to discuss a multi-year framework. Those are exactly the signs a reader should want to see when a defense technology starts moving out of the lab.
But QCL is also not yet a fully formed commercial engine. The hard numbers are still small, the largest framework was still conditional, and the company itself says the route still depends on technology thresholds, development pace, manpower and broader operational and manufacturing capacity. So, at the current evidence point, the more precise label is not a built engine, but a proof year for one.
The thesis now: QCL has moved from feasibility proof to early commercialization proof, but it still has not demonstrated repeatability, scale and certainty at the level needed to treat it today as a fully developed commercial engine.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.